bibliographicCitation |
Yoshida H, Sato-Dahlman M, Hajeri P, Jacobsen K, Koodie L, Yanagiba C, Shanley R, Yamamoto M. Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells. Translational Oncology. 2021 Feb;14(2):100997. doi: 10.1016/j.tranon.2020.100997. |